RNR RenaissanceRe Holdings Ltd.

323.03USD-0.43%Mkt Cap: 13.42B $P/E: 5.58

RenaissanceRe Holdings Ltd., together with its subsidiaries, provides reinsurance and insurance products in the United States and internationally. The company operates through Property, and Casualty and Specialty segment…

HeadlineSourceTime
Older
CNA Stock Trading at a Discount to Industry at 1.11X: Time to Hold?

CNA Financial's premium growth, strong investment income and Specialty momentum support earnings, while casualty claims and softer pricing pose risks.

Zacks
Is RenaissanceRe Holdings (RNR) Still A Bargain After A 142% Run?

RenaissanceRe Holdings has had a powerful run over the past few years, and the stock is still changing hands near recent highs. That kind of track record naturally raises a question for holders and onlookers alike: is the current share price still supported by the insurer's earnings power? Over the past 5 years the stock has gained 142.0%, which puts real pressure on the current P/E and related earnings multiples to carry that performance story forward. For a reinsurer like RenaissanceRe,...

Simply Wall St.
Is RenaissanceRe Holdings (RNR) Undervalued On Its Diversified Reinsurance Story?

RenaissanceRe Holdings (RNR) is back on watch after recent trading left the share price around $325.60, with returns mixed over the past week, month and past 3 months. Recent trading has cooled near term momentum, with the 1-day share price return down 1.46% and the 30-day share price return down 1.55%. Even so, RenaissanceRe Holdings still carries a 19.60% year to date share price gain and a 1-year total shareholder return of 30.64%, extending to 141.99% over five years. This points to...

Simply Wall St.
NMI Holdings Near 52-Week High: Time to Buy, Sell or Hold the Stock?

NMIH's strong insurance growth, improving credit performance and capital position support premium growth and shareholder returns.

Zacks
3 Reasons RNR is Risky and 1 Stock to Buy Instead

RenaissanceRe trades at $328.71 per share and has stayed right on track with the overall market, gaining 11.2% over the last six months. At the same time, the S&P 500 has returned 14%.

StockStory
FAF Stock Outperforms Industry: Time to Buy for Solid Returns?

FAF's commercial growth, rising deposits and AI adoption support earnings, while housing weakness and commercial exposure pose risks.

Zacks
RenaissanceRe Trades at a Discount to Peers: Hold or Fold?

RNR's discounted valuation and stronger underwriting are compelling, but falling premiums and rising debt costs create key risks for investors.

Zacks
The Zacks Analyst Blog Highlights RenaissanceRe, Arch Capital, Everest

RenaissanceRe, Arch Capital and Everest are positioned to benefit as alternative capital expands, boosting capacity and reshaping reinsurance.

Zacks
3 Reinsurers Set to Benefit From Alternative Capital Boom

Alternative capital is set to reshape reinsurance, creating growth opportunities for reinsurers that combine strong underwriting with third-party capital.

Zacks
Why Is Mercury General (MCY) Down 6.1% Since Last Earnings Report?

Mercury General (MCY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks
Q2 Earnings Highlights: RenaissanceRe (NYSE:RNR) Vs The Rest Of The Reinsurance Stocks

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at reinsurance stocks, starting with RenaissanceRe (NYSE:RNR).

StockStory
RenaissanceRe's ILS Platform Supports Fee-Based Earnings Growth

RNR leverages growing ILS capacity to expand fee income, providing an earnings stream beyond traditional underwriting.

Zacks
3 Unpopular Stocks We Think Twice About

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.

StockStory
CNA Lags Industry, Trades at a Discount: Time to Hold or Buy?

CNA Financial's premium growth, strong investment income and disciplined underwriting support earnings, while casualty claims and softer pricing pose risks.

Zacks
Why Is RenaissanceRe (RNR) Up 1.5% Since Last Earnings Report?

RenaissanceRe (RNR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks
3 Insurance Stocks That Concern Us

Insurance companies serve as the backbone of risk management, providing essential protection and financial security for individuals and businesses. Market leaders have certainly capitalized on strong underwriting results and rising investment income to boost profitability, helping fuel a 11.7% gain for the industry over the past six months. This performance has closely followed the S&P 500.

StockStory
NMIH Gains 20.9% in Three Months: What Investors Should Know?

NMI Holdings' strong insurance growth, credit performance and capital position support earnings, with buybacks adding to shareholder value.

Zacks
FAF Stock Trading at a Discount to Industry at 1.30X: Time to Hold?

First American's commercial growth, rising investment income and AI-driven efficiencies support long-term earnings, despite housing and CRE risks.

Zacks
Will Lower Underwriting Profit Hurt Accelerant Holdings' Q2 Results?

ARX's Q2 results may face pressure from weaker Underwriting and MGA profitability despite strong premium and investment income growth.

Zacks
RenaissanceRe (RNR) Stock Looks Undervalued On Earnings But Risky On Loss Exposure

RenaissanceRe Holdings has quietly delivered a strong 108.0% total return over the past 5 years, yet its current valuation checks still suggest the stock leans on the cheap side rather than fully priced in. Over 5 years, a 108.0% return signals that long term shareholders in RenaissanceRe Holdings have already seen solid gains, so fresh buyers need to think carefully about what is still priced in. For a reinsurer like RenaissanceRe Holdings, investor expectations around underwriting...

Simply Wall St.
MetLife Tops Q2 Earnings Estimates on Strong Investment Income

MET tops Q2 EPS estimates as higher investment income, favorable underwriting and business volume growth lift earnings despite higher expenses.

Zacks
Allstate Q2 Earnings Beat Estimates on Higher Investment Income

ALL beats Q2 earnings estimates as higher investment income, improved underwriting and lower catastrophe losses fuel strong profit growth.

Zacks
Will Investment Income Headwinds Weigh on AIG's Q2 Results?

American International heads into Q2 earnings with premium growth expectations, but a sharp drop in net investment income could cloud results and keep an earnings beat uncertain.

Zacks
CNO Financial Beats Q2 Earnings Estimates on Higher Collected Premiums

CNO posts a Q2 earnings beat as higher collected premiums and net investment income lift results, prompting the company to raise its 2026 EPS outlook.

Zacks